EMT in cervical cancer: Its role in tumour progression and response to therapy

被引：257
作者：
Qureshi, Rehana [1 ]
Arora, Himanshu [2 ]
Rizvi, M. A. [1 ]
机构：
[1] Jamia Millia Islamia, Dept Biosci, Genome Biol Lab, New Delhi 110025, India
[2] Univ Strasbourg, ESBS API Pole, CNRS, IREBS UMR7242, F-67412 Illkirch Graffenstaden, France
来源：
CANCER LETTERS | 2015年 / 356卷 / 02期
关键词：
Epithelial Mesenchymal Transition; Mesenchymal transition (EMT); Therapeutics; Oncogene; Tumour-suppressor; Cervical cancer; EPITHELIAL-MESENCHYMAL TRANSITION; ASTROCYTE-ELEVATED GENE-1; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; FUSED TOES HOMOLOG; CELL-MIGRATION; E-CADHERIN; DOWN-REGULATION; MIR-200; FAMILY;
D O I：
10.1016/j.canlet.2014.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prognosis of cervical patients significantly decreases as the cancer metastasizes to other parts of the body. The epithelial to mesenchymal transition (EMT) plays an important role in cervical cancer progression and metastasis. Recurrence is the primary cause of the increased number of deaths due to cervical cancer. Oncogenes, such as AEG1, Sam-68, FTS and miR-361-5p, induce EMT in cervical cancer. Tumour suppressors, such as LMX-1, SFRP1, klotho, and miR-155, suppress EMT in cervical cancer. Factors such as hypoxia, the radiation dose, cytokines, proteins, transcription factors, and signalling pathways also play an important role in the induction, progression and maintenance of EMT in cervical cancer. Overall, this review describes a wide range of factors with potential roles in EMT that have been identified to date, and this information could be important for the development of new and more effective therapeutics that ameliorate the negative impact of cervical pathogenesis via EMT. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：321 / 331
页数：11
相关论文
共 167 条
[101]   DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries [J].
Nakamura, T ;
Ruiz-Lozano, P ;
Lindner, V ;
Yabe, D ;
Taniwaki, M ;
Furukawa, Y ;
Kobuke, K ;
Tashiro, K ;
Lu, ZJ ;
Andon, NL ;
Schaub, R ;
Matsumori, A ;
Sasayama, S ;
Chien, KR ;
Honjo, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22476-22483
[102]  
Ndubisi B, 1997, ANN CLIN LAB SCI, V27, P396
[103]   Cytotoxic prenylated flavonoids from Morus alba [J].
Nguyen Tien Dat ;
Phung Thi Xuan Binh ;
Le Thi Phuong Quynh ;
Chau Van Minh ;
Hoang Thanh Huong ;
Lee, Jung Joon .
FITOTERAPIA, 2010, 81 (08) :1224-1227
[104]   Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer [J].
Noordhuis, Maartje G. ;
Fehrmann, Rudolf S. N. ;
Wisman, G. Bea A. ;
Nijhuis, Esther R. ;
van Zanden, Jelmer J. ;
Moerland, Perry D. ;
van Themaat, Emiel Ver Loren ;
Volders, Haukeline H. ;
Kok, Mirjam ;
ten Hoor, Klaske A. ;
Hollema, Harry ;
de Vries, Elisabeth G. E. ;
de Bock, Geertruida H. ;
van der Zee, Ate G. J. ;
Schuuring, Ed .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1317-1330
[105]  
O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926
[106]   PRINCIPLES OF BIOTHERAPY AND ITS APPLICATION TO THE TREATMENT OF DISSEMINATED RENAL-CANCER [J].
OCONNOR, TE ;
WEST, WH ;
MARSHALL, GD ;
ORR, DW ;
LEWIS, M ;
OLDHAM, RK .
SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (03) :155-160
[107]   Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development [J].
Orlichenko, Lidiya S. ;
Radisky, Derek C. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :593-600
[108]   Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer [J].
Pan, Jie ;
Zhong, Jing ;
Gan, Li Hong ;
Chen, Shu Jie ;
Jin, Hong Chuan ;
Wang, Xian ;
Wang, Liang Jing .
TUMOR BIOLOGY, 2011, 32 (04) :729-735
[109]   The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 [J].
Park, Sun-Mi ;
Gaur, Arti B. ;
Lengyel, Ernst ;
Peter, Marcus E. .
GENES & DEVELOPMENT, 2008, 22 (07) :894-907
[110]   Estimating the world cancer burden: GLOBOCAN 2000 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) :153-156
6789101112131415